These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21902627)

  • 1. Targeting stenosis with nucleotide-hydrolyzing enzymes.
    Kaczmarek E; Koziak K
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1799-804. PubMed ID: 21902627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ecto-nucleotidases of ectonucleoside triphosphate diphosphohydrolase family: structure, localization and functional significance].
    Iablons'ka SV; Rybal'chenko VK
    Ukr Biokhim Zh (1999); 2010; 82(3):5-17. PubMed ID: 21328873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.
    Atkinson B; Dwyer K; Enjyoji K; Robson SC
    Blood Cells Mol Dis; 2006; 36(2):217-22. PubMed ID: 16476557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
    Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
    Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling.
    Kishore BK; Isaac J; Fausther M; Tripp SR; Shi H; Gill PS; Braun N; Zimmermann H; Sévigny J; Robson SC
    Am J Physiol Renal Physiol; 2005 May; 288(5):F1032-43. PubMed ID: 15632415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectonucleotidases in the nervous system.
    Zimmermann H
    Novartis Found Symp; 2006; 276():113-28; discussion 128-30, 233-7, 275-81. PubMed ID: 16805426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological roles of purinergic signaling in the liver.
    Vaughn BP; Robson SC; Burnstock G
    J Hepatol; 2012 Oct; 57(4):916-20. PubMed ID: 22709619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectonucleotidases in Inflammation, Immunity, and Cancer.
    Haas CB; Lovászi M; Braganhol E; Pacher P; Haskó G
    J Immunol; 2021 May; 206(9):1983-1990. PubMed ID: 33879578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
    Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
    Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic potential of CD39: interview with Dr Simon Robson by Emma Quigley.
    Robson S
    Expert Opin Ther Targets; 2006 Oct; 10(5):649-52. PubMed ID: 16981822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning from rejection: what transplantation teaches us about (other) vascular pathologies.
    Mitchell RN
    J Autoimmun; 2013 Sep; 45():80-9. PubMed ID: 23830871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fusion protein of the human P2Y(1) receptor and NTPDase1 exhibits functional activities of the native receptor and ectoenzyme and reduced signaling responses to endogenously released nucleotides.
    Alvarado-Castillo C; Lozano-Zarain P; Mateo J; Harden TK; Boyer JL
    Mol Pharmacol; 2002 Sep; 62(3):521-8. PubMed ID: 12181428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.
    Noronha-Matos JB; Costa MA; Magalhães-Cardoso MT; Ferreirinha F; Pelletier J; Freitas R; Neves JM; Sévigny J; Correia-de-Sá P
    J Cell Physiol; 2012 Jun; 227(6):2694-709. PubMed ID: 21898410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthroughs spotlighting roles for extracellular nucleotides and apyrases in stress responses and growth and development.
    Clark GB; Morgan RO; Fernandez MP; Salmi ML; Roux SJ
    Plant Sci; 2014 Aug; 225():107-16. PubMed ID: 25017166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic Receptors in Thrombosis and Inflammation.
    Hechler B; Gachet C
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Purinergic signals].
    Lazarowski ER; Schwarzbaum PJ
    Medicina (B Aires); 2009; 69(2):267-76. PubMed ID: 19435702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury.
    Grenz A; Zhang H; Hermes M; Eckle T; Klingel K; Huang DY; Müller CE; Robson SC; Osswald H; Eltzschig HK
    FASEB J; 2007 Sep; 21(11):2863-73. PubMed ID: 17442731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of P2 Purinergic Receptors in Mesenchymal Stem Cells and Their Roles in Extracellular Nucleotide Regulation of Cell Functions.
    Jiang LH; Hao Y; Mousawi F; Peng H; Yang X
    J Cell Physiol; 2017 Feb; 232(2):287-297. PubMed ID: 27403750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTPDase1 and NTPDase2 immunolocalization in mouse cochlea: implications for regulation of p2 receptor signaling.
    Vlajkovic SM; Thorne PR; Sévigny J; Robson SC; Housley GD
    J Histochem Cytochem; 2002 Nov; 50(11):1435-42. PubMed ID: 12417608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.